Floatz logo

DEXKETOPROFEN

Low Anterior Resection Syndrome (LARS)

Althaia Xarxa Assistencial Universitària de ManresaSmall moleculeN/AActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

2 Active assets in the Low Anterior Resection Syndrome (LARS) cohort.

Asset / SponsorPhaseRating
METAMIZOLE
Althaia Xarxa Assistencial Universitària de Manresa
N/AD
NEPENTHE
Althaia Xarxa Assistencial Universitària de Manresa
N/AD

Same molecule, other indications

DEXKETOPROFEN is also rated in:

migraine disorderDormant
BBB
Indicative ·
73 / 100
View asset →
migraine without auraDormant
BB
Indicative ·
68 / 100
View asset →
Carcinoma, HepatocellularDormant
BB
Indicative ·
67 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →